Patent · US Active

Compounds with thymine skeleton for use in medicine

US11214564B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Technische Universitaet Dresden · DE

Inventors

Michael Schroeder · Hankinson, US
Yixin Zhang · Dresden, DE
Jörg Heinrich · Grünwald, DE
Joachim Haupt · Freiberg, DE
Petra Lennig · Mainz, DE

Key dates

Filing date	Nov 3, 2020
Grant date	Jan 4, 2022
Priority date	—
Expiry date	Nov 3, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel compounds as new chemical entities with thymine skeleton, these compounds for use as in medicine, especially in the treatment of carcinoma, HSP27-associated diseases and cystic fibrosis; and a pharmaceutical product containing at least one of these compounds. Finally, a method of production of that novel compounds is presented.General formula of these compounds is formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.